On December 1, 2023, CureSHANK announced its Request for Applications (RFA) for the CureSHANK Research-to-Cure Grant: Epilepsy.

This year, we are pleased to be dedicating $450,000 toward several research projects targeting many of Phelan-McDermid syndrome’s most challenging symptoms.